News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Johnson & Johnson (JNJ) Wins Risperdal Suit in Pennsylvania, Again



7/30/2012 7:32:42 AM

A state court in Pennsylvania has uphead an earlier ruling dismissing a lawsuit against Johnson & Johnson for alleged improper marketing of Risperdal. The decision comes three years after a trial court first dismissed the lawsuit, saying the state had not provided enough evidence. The state initially filed suit in 2007, claiming the drugmaker hid Risperdal health risks and caused $289 million in alleged overcharges to prescriptions covered by state-sponsored health plans. he original lawsuit was based on evidence provided by Allen Jones, a former fraud investigator with the Pennsylvania Inspector General’s Office. In 2001, Pennsylvania was considering whether to adopt guidelines in the Texas Medication Algorithm Project, a state system protocol for treating psychiatric disorders. Jones contended that J&J engaged in a widespread scheme to ensure state Medicaid officials would give Risperdal preferential treatment.

Read at Pharmalot


comments powered by Disqus
Pharmalot
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES